Financials

  • Market Capitalization 27.02 M
  • Employee 70
  • Founded 2005
  • CEO N/A
  • Website www.igcinc.us
  • Headquarter Maryland, United States
  • FIGI BBG000NSSLY8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.29
Price to sales ratio
19.33

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4480
KYNB
Kyntra Bio, Inc. - Common Stock
7.05 USD+0.28%-0.14%-2.62%-25.87%28.54 M USD
4485
ACTU
Actuate Therapeutics, Inc. - Common stock
1.15 USD-2.54%-18.44%-33.53%-71.81%27.51 M USD
4495
BTAI
BioXcel Therapeutics, Inc. - Common Stock
0.87 USD+2.35%-2.25%-32.03%-44.94%26.86 M USD
4497
ATNM
Actinium Pharmaceuticals, Inc. Common Stock
0.85 USD-1.16%-4.49%-14.14%-18.27%26.67 M USD

Frequently asked questions about IGC Pharma, Inc. Common Stock

What is the IGC Pharma, Inc. Common Stock stock price today?

The current price of IGC Pharma, Inc. Common Stock (IGC) is 0.27. Over the past 24 hours, the stock has changed by 0.00%. Follow the IGC chart for real-time price dynamics.

What is the stock ticker of IGC Pharma, Inc. Common Stock?

IGC Pharma, Inc. Common Stock trades under the ticker IGC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is IGC Pharma, Inc. Common Stock stock going up?

IGC has changed by 0.00% over the last week, +3.85% over the last month, and +5.39% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was IGC Pharma, Inc. Common Stock net income for the last quarter?

IGC Pharma, Inc. Common Stock reported net income of -2.4 M for the last quarter. The previous quarter showed -1.82 M, which means net income changed by -31.91%.

How many employees does IGC Pharma, Inc. Common Stock have?

As of the latest available data, IGC Pharma, Inc. Common Stock has 70 employees. Workforce size can provide additional context about the company's scale and operations.

What is IGC Pharma, Inc. Common Stock EBITDA?

IGC Pharma, Inc. Common Stock EBITDA is -2.42 M, and its EBITDA margin is -762.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy IGC Pharma, Inc. Common Stock stock?

You can buy IGC Pharma, Inc. Common Stock (IGC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in IGC Pharma, Inc. Common Stock stock?

Investing in IGC Pharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IGC chart and related analysis on metatrader.com as part of your research.

News